Beyond The Numbers: 9 Analysts Discuss Tempus AI Stock
TEMApril 24, 2025
Read more →Needham Reiterates Buy on Tempus AI, Maintains $70 Price Target
TEMApril 24, 2025
Read more →BTIG Initiates Coverage On Tempus AI with Buy Rating, Announces Price Target of $60
TEMApril 21, 2025
Read more →Needham Reiterates Buy on Tempus AI, Maintains $70 Price Target
TEMApril 10, 2025
Read more →Tempus AI Acquires Deep 6 AI; No Terms Disclosed
TEMMarch 11, 2025
Read more →Morgan Stanley Maintains Overweight on Tempus AI, Raises Price Target to $60
TEMMarch 6, 2025
Read more →Piper Sandler Maintains Neutral on Tempus AI, Lowers Price Target to $55
TEMMarch 4, 2025
Read more →B of A Securities Maintains Neutral on Tempus AI, Raises Price Target to $60
TEMMarch 3, 2025
Read more →Guggenheim Reiterates Buy on Tempus AIto Buy
TEMFebruary 25, 2025
Read more →Tempus AI Stock Is Tumbling Tuesday: What's Happening?
TEMTempus AI Inc (NASDAQ:TEM) shares are trading lower Tuesday after the company reported mixed fourth-quarter financial results. JPMorgan also downgraded the stock following the print.
February 25, 2025
Read more →Tempus AI Inc Files For Offering Of Up To 4.84M Shares Of Class A Common Stock By The Selling Stockholder
TEMFebruary 25, 2025
Read more →Needham Maintains Buy on Tempus AI, Raises Price Target to $70
TEMFebruary 25, 2025
Read more →The Analyst Verdict: Tempus AI In The Eyes Of 7 Experts
TEMFebruary 25, 2025
Read more →JP Morgan Downgrades Tempus AI to Neutral, Raises Price Target to $55
TEMFebruary 25, 2025
Read more →Tempus AI Q4 Earnings: Revenue Miss, EPS Beat, Strong Guidance, Shares Move Lower
TEMTempus AI reports fourth-quarter revenue of $200.68 million, missing estimates of $203.12 million.
February 24, 2025
Read more →Tempus Now Expects 2025 Revenue Of $1.24B (Est $1.021B) And Expects Adjusted EBITDA Of ~$5M, Up ~$110M Over 2024
TEMFebruary 24, 2025
Read more →Tempus AI Q4 2024 Adj EPS $(0.18) Beats $(0.20) Estimate, Sales $200.68M Miss $203.12M Estimate
TEMFebruary 24, 2025
Read more →What's Going On With Tempus AI Shares Monday?
TEMTempus shares may be moving higher ahead of its 2024 fiscal-year fourth-quarter earnings report, which is scheduled to be released after the market closes.
February 24, 2025
Read more →Tempus AI Gears Up For Q4 Earnings After 101% YTD Surge
TEMTempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD. Analysts see 13.5% upside with consensus rating of Buy and $59.60 price target.
February 24, 2025
Read more →Tempus And Stemline Therapeutics Enter Into Partnership To Implement AI-Enabled Platform For Metastatic Breast Cancer Care
TEMFebruary 21, 2025
Read more →What's Going On With Tempus AI Shares Thursday?
TEMTempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Thursday after the company announced a collaboration with the Institute for Follicular Lymphoma Innovation.
February 13, 2025
Read more →Tempus Collaborates With IFLI Aimed For Development Of Targeted Therapies for Follicular Lymphoma Patients
TEMFebruary 13, 2025
Read more →William Blair Downgrades Tempus AI to Market Perform
TEMFebruary 12, 2025
Read more →Tempus Announces The Launch Of FDA-Approved xT CDx Test, Now Available For All Ordering Clinicians Nationwide
TEMJanuary 15, 2025
Read more →Loop Capital Maintains Buy on Tempus AI, Lowers Price Target to $52
TEMJanuary 14, 2025
Read more →Beyond The Numbers: 6 Analysts Discuss Tempus AI Stock
TEMJanuary 14, 2025
Read more →Needham Reiterates Buy on Tempus AI, Maintains $56 Price Target
TEMJanuary 14, 2025
Read more →Tempus AI Announces FY24 Preliminary Q4 Revenue At $200M, 35% YoY Growth; FY24 Revenue $693M , 30% YoY Growth
TEMJanuary 13, 2025
Read more →Tempus Announces That It Has Entered Into An Agreement To Acquire Ambry Genetics For $375M In Cash And $225M In Shares At Closing
TEMNovember 4, 2024
Read more →Tempus Continues To Expect FY24 Revenue Of ~$700M, Which Represents ~32% YoY Growth And ~$(105M) In Adj EBITDA, An Improvement Of ~$50M Over 2023
TEMNovember 4, 2024
Read more →Tempus AI Q3 EPS $(0.46) Misses $(0.44) Estimate, Sales $180.93M Beat $179.52M Estimate
TEMNovember 4, 2024
Read more →